mbs2320
Small moleculeexperimental
Clinical trial activity
5 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2015 (NCT02480946)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Loading structure…
SMILES
C[C@]1(O)CC[C@H](NS(=O)(=O)c2ccc(-c3ccc(Cl)c(C#N)c3)cc2)CC1- Mol. weight
- 404.92 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL5314525 ↗
Also known as
- mbs2320
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06379958 | Phase 1 | Apr 8, 2024 | Modern Biosciences plc |
| NCT05951296 | Phase 2 | Aug 30, 2023 | Modern Biosciences plc |
| NCT05460832 | Phase 2 | Aug 29, 2022 | Modern Biosciences plc |
| NCT03139136 | Phase 2 | May 1, 2017 | Modern Biosciences plc |
| NCT02480946 | Phase 1 | Jul 1, 2015 | Covance, Modern Biosciences plc |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Modern Biosciences plc | For profit | 5 | 5 | 2 | 2015 |
| Covance | For profit | 1 | 0 | 1 | 2015 |
2 organizations
Page 1 / 1